**Author details**

Irina Diana Bobolea1,2\*, Carlos Melero2,3 and Jesús Jurado-Palomo4

*appearance of serious adverse events, especially severe infections and malignancies* [64]*.*

\*Address all correspondence to: ibobolea@gmail.com

1 Department of Allergology Hospital Doce de Octubre Institute for Health Research (i+12), Madrid, Spain

2 Highly-specialized Severe Asthma Unit Hospital Doce de Octubre Institute for Health Re‐ search (i+12), Madrid, Spain

3 Department of Pulmonology Hospital Doce de Octubre Institute for Health Research (i +12), Madrid, Spain

4 Department of Allergology Nuestra Señora del Prado General Hospital, Talavera de la Re‐ ina, Spain
